Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.97)
# 89
Out of 4,630 analysts
1216
Total ratings
57.4%
Success rate
37%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.26 | +666.87% | 28 | Aug 10, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $70 | $43.96 | +59.24% | 45 | Aug 10, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterated: Buy | $45 | $3.41 | +1,219.65% | 12 | Aug 10, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $20 | $8.89 | +124.97% | 67 | Aug 10, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $80 | $27.26 | +193.47% | 28 | Aug 10, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | $75 | $15.51 | +383.56% | 43 | Aug 10, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $50 | $7.24 | +590.61% | 22 | Aug 10, 2026 | |
| GHRS GH Research | Reiterated: Buy | $65 | $29.69 | +118.93% | 40 | Aug 10, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $115 → $120 | $88.35 | +35.82% | 72 | Aug 7, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $70 → $65 | $13.13 | +395.05% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $28.43 | +111.04% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $485 → $455 | $217.83 | +108.88% | 77 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $39.01 | +40.99% | 27 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.42 | +708.63% | 66 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $46.17 | +73.27% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $3.00 | +567.78% | 49 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,000p | 41p | +2,339.02% | 27 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.1792 | +1,016.07% | 50 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $15.05 | +132.56% | 2 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $10.41 | +572.43% | 44 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $7.5 | $7.26 | +3.38% | 56 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.7857 | +1,172.75% | 50 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.14 | +777.19% | 7 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.6772 | +1,376.67% | 38 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $79.12 | +83.27% | 14 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $27.54 | +81.55% | 20 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $34.84 | +72.24% | 9 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.105 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $26.60 | +87.97% | 14 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $33.75 | +196.30% | 52 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $10 | $1.25 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $360 | $15.79 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.52 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.055 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 6p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €33.00 | €3.66 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $46.88 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $130 | $13.69 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $12.53 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.07 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $20.61 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $108.61 | n/a | 1 | Dec 23, 2014 |
Voyager Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $25
Current: $3.26
Upside: +666.87%
Definium Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $70
Current: $43.96
Upside: +59.24%
NRx Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $45
Current: $3.41
Upside: +1,219.65%
Vir Biotechnology
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $8.89
Upside: +124.97%
Beam Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $80
Current: $27.26
Upside: +193.47%
Silence Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $75
Current: $15.51
Upside: +383.56%
Aligos Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $7.24
Upside: +590.61%
GH Research
Aug 10, 2026
Reiterated: Buy
Price Target: $65
Current: $29.69
Upside: +118.93%
Arrowhead Pharmaceuticals
Aug 7, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $88.35
Upside: +35.82%
COMPASS Pathways
Aug 7, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $13.13
Upside: +395.05%
Aug 5, 2026
Reiterated: Buy
Price Target: $60
Current: $28.43
Upside: +111.04%
Aug 4, 2026
Reiterated: Buy
Price Target: $485 → $455
Current: $217.83
Upside: +108.88%
Aug 4, 2026
Reiterated: Buy
Price Target: $55
Current: $39.01
Upside: +40.99%
Aug 3, 2026
Reiterated: Buy
Price Target: $60
Current: $7.42
Upside: +708.63%
Jul 30, 2026
Reiterated: Buy
Price Target: $80
Current: $46.17
Upside: +73.27%
Jul 28, 2026
Maintained: Buy
Price Target: $20
Current: $3.00
Upside: +567.78%
Jul 28, 2026
Reiterated: Buy
Price Target: 1,000p
Current: 41p
Upside: +2,339.02%
Jul 28, 2026
Reiterated: Buy
Price Target: $2
Current: $0.1792
Upside: +1,016.07%
Jul 22, 2026
Reiterated: Buy
Price Target: $35
Current: $15.05
Upside: +132.56%
Jul 21, 2026
Reiterated: Buy
Price Target: $70
Current: $10.41
Upside: +572.43%
Jul 20, 2026
Downgraded: Hold
Price Target: $25 → $7.5
Current: $7.26
Upside: +3.38%
Jul 13, 2026
Reiterated: Buy
Price Target: $10
Current: $0.7857
Upside: +1,172.75%
Jul 9, 2026
Reiterated: Buy
Price Target: $10
Current: $1.14
Upside: +777.19%
Jul 8, 2026
Reiterated: Buy
Price Target: $10
Current: $0.6772
Upside: +1,376.67%
Jun 25, 2026
Reiterated: Buy
Price Target: $145
Current: $79.12
Upside: +83.27%
Jun 25, 2026
Reiterated: Buy
Price Target: $50
Current: $27.54
Upside: +81.55%
Jun 16, 2026
Reiterated: Buy
Price Target: $60
Current: $34.84
Upside: +72.24%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.105
Upside: -
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $26.60
Upside: +87.97%
Jun 3, 2026
Reiterated: Buy
Price Target: $100
Current: $33.75
Upside: +196.30%
Apr 2, 2025
Maintained: Buy
Price Target: $25 → $10
Current: $1.25
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $20 → $360
Current: $15.79
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $13.52
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.055
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 6p
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: €33.00
Current: €3.66
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $46.88
Upside: n/a
Sep 18, 2019
Maintained: Buy
Price Target: $120 → $130
Current: $13.69
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $12.53
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $4.07
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $20.61
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $108.61
Upside: n/a